Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 16, 2019 (Event Date)
Reporting Period: Specific events occurring between August 13, 2019, and August 21, 2019.
Key Financial Metrics and Capital Structure
This filing details equity transactions rather than operational financial performance. No revenue, profit, cash flow, or margin data is provided in this document.
- Total Shares Issued: 3,254,207 shares of Class A Common Stock.
- Dilution Impact: Represents approximately 3.4% of Class A Common Stock outstanding post-issuance.
- Expected Future Issuance: Approximately 80,422 additional shares expected on September 3, 2019, contingent on the redemption of untendered Public Warrants.
Material Changes and Transactions
The filing reports the completion of a warrant exchange offer and related equity issuances:
- Public Warrant Exchange: On August 21, 2019, the Company issued 2,845,280 shares in exchange for Public Warrants validly tendered under an offer that expired on August 16, 2019. The exchange ratio was 0.095 shares per warrant.
- Private Placement Exchange: The Company issued 389,501 shares to PIPE Investors (Avista Capital Partners IV L.P. and Avista Capital Partners IV (Offshore), L.P.) in exchange for 4,100,000 private placement warrants.
- Net Exercise: On August 13, 2019, Lender Warrant Holders net exercised warrants to purchase 182,700 shares at $3.95 per share, resulting in the issuance of 19,426 shares.
- Redemption: Remaining untendered Public Warrants are scheduled to be exchanged on September 3, 2019, pursuant to a Warrant Amendment executed on August 19, 2019.
Guidance, Outlook, and Risks
Management Commentary: The Company confirmed that the warrant exchange offer expired as scheduled and that issuances were made pursuant to exemptions under Section 3(a)(9) and Section 4(a)(2) of the Securities Act of 1933. No commissions were paid for soliciting the exchanges.
Risks and Contingencies: The issuance of approximately 80,422 additional shares is contingent on holders of untendered Public Warrants not exercising them prior to 5:00 p.m. Eastern Time on September 3, 2019.
Investor Verification Checklist
- Verify the final count of shares issued on August 21, 2019, against the 3,254,207 figure reported.
- Confirm the status of the September 3, 2019, redemption of remaining Public Warrants and the resulting share count.
- Review the impact of the 3.4% dilution on existing shareholder ownership percentages.
- Check subsequent filings for any changes to the Warrant Amendment terms or the PIPE Investor agreement.